The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...
Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from ...
It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...
Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...
Steele, who joined the FDA in 2022, was previously senior adviser at the Center for Biologics Evaluation and Research, which regulates biological and related products including blood, vaccines, ...
The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, ...